Daniel E. Zak
Impact in
- Infectious Diseases top 1%
- Tuberculosis Research and Epidemiology
- Immunology top 2%
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- Immune responses and vaccinations
Papers in
-
- Tuberculosis Research and Epidemiology 23
- Immunology 10
- Immune Response and Inflammation 6
- T-cell and B-cell Immunology 2
- Co-authors
- Alan A. Aderem (18 shared papers)Edward A. Miao (2 shared papers)Russell E. Vance (2 shared papers)Ilya Shmulevich C (4 shared papers)Mary F. Fontana (1 shared paper)Peggy A. Cotter (1 shared paper)Irina A. Leaf (1 shared paper)Youssef Aachoui (1 shared paper)
- Journals
- Frontiers in Immunology (4 papers)Proceedings of the National Academy of Sciences (4 papers)Tuberculosis (3 papers)Journal of Clinical Investigation (2 papers)The Lancet (2 papers)
- Partner nations
- United StatesSouth AfricaUnited Kingdom
In The Last Decade
Daniel E. Zak
51 papers receiving 4.6k citations
Daniel E. Zak's Hit Papers
Peers
Comparison fields: 5 of 112
- Infectious Diseases 2k
- Immunology 805
- Virology 160
- Molecular Biology 1.2k
- Endocrinology 45
Countries citing papers authored by Daniel E. Zak
This map shows the geographic impact of Daniel E. Zak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel E. Zak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel E. Zak more than expected).
Fields of papers citing papers by Daniel E. Zak
This network shows the impact of papers produced by Daniel E. Zak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel E. Zak. The network helps show where Daniel E. Zak may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel E. Zak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A blood RNA signature for tuberculosis disease risk: a prospective cohort study Hit paper breakdown → | 2016 | 652 |
| 2 | 2013 | 464 | |
| 3 | 2009 | 248 | |
| 4 | 2017 | 236 | |
| 5 | 2018 | 206 | |
| 6 | 2018 | 205 | |
| 7 | 2017 | 193 | |
| 8 | 2013 | 164 | |
| 9 | 2017 | 158 | |
| 10 | 2008 | 149 | |
| 11 | 2012 | 140 | |
| 12 | 2016 | 134 | |
| 13 | 2018 | 129 | |
| 14 | 2020 | 123 | |
| 15 | 2008 | 120 | |
| 16 | 2003 | 104 | |
| 17 | 2015 | 93 | |
| 18 | 2020 | 92 | |
| 19 | 2017 | 83 | |
| 20 | 2019 | 80 |
About Daniel E. Zak
Daniel E. Zak is a scholar working on Infectious Diseases, Immunology, Virology, Endocrine and Autonomic Systems and Molecular Biology, having authored 51 papers that have together received 4.7k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (23 papers), Gene Regulatory Network Analysis (8 papers), Immune Response and Inflammation (6 papers), Circadian rhythm and melatonin (4 papers), HIV Research and Treatment (4 papers), Genomics and Chromatin Dynamics (3 papers), Inflammasome and immune disorders (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Infectious Diseases (2k citations), Immunology (805 citations), Virology (160 citations), Molecular Biology (1.2k citations) and Endocrinology (45 citations). Daniel E. Zak has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Alan A. Aderem, Edward A. Miao, Russell E. Vance, Ilya Shmulevich C, Mary F. Fontana, Peggy A. Cotter, Irina A. Leaf, Youssef Aachoui, Cristine G. Campos and Jon A. Hagar. Their work appears in journals such as Frontiers in Immunology, Proceedings of the National Academy of Sciences, Tuberculosis, Journal of Clinical Investigation and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.